Aarti Drugs PAT declines 43% yoy to Rs48.8cr in Q1FY22; Stock slumps ~6%

The companys revenue from operations in Q1FY22 stood at Rs581.6cr as against Rs545.9cr, up 6.5% yoy. Concludes Rs60cr share buyback.

from India Infoline News Service https://ift.tt/3BNttV1